4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Beam Therapeutics Inc. (BEAM) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 522 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, BEAM reported $140M in revenue and ($80M) in net income.
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
Interactive charts & full statements → Open the BEAM valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $140M | $64M | $378M | $61M | — |
| Operating Income (EBIT) | ($384M) | ($416M) | ($176M) | ($338M) | — |
| Net Income | ($80M) | ($377M) | ($132M) | ($289M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $32M | $114M | $10M | $8M | $8M | — |
| Operating Income (EBIT) | ($107M) | ($17M) | ($127M) | ($120M) | ($119M) | — |
| Net Income | ($94M) | $244M | ($113M) | ($102M) | ($108M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.5B | $1.1B | $1.5B | $1.3B | — |
| Total Liabilities | $243M | $370M | $478M | $608M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BEAM viewer.
About TickerBase · Data methodology & sources